Effect of leukoreduction and temperature on risk of bacterial growth in CPDA-1 whole blood: A study of Escherichia coli.
CPDA-1 whole blood
E. coli
contamination
leukoreduction
phagocytosis
storage
walking blood bank
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
01
02
2021
received:
02
12
2020
accepted:
01
02
2021
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
17
8
2021
Statut:
ppublish
Résumé
Collection of non-leukoreduced citrate-phosphate-dextrose-adenine (CPDA-1) whole blood is performed in walking blood banks. Blood collected under field conditions may have increased risk of bacterial contamination. This study was conducted to examine the effects of WBC reduction and storage temperature on growth of Escherichia coli (ATCC® 25922™) in CPDA-1 whole blood. CPDA-1 whole blood of 450 ml from 10 group O donors was inoculated with E. coli. Two hours after inoculation, the test bags were leukoreduced with a platelet-sparing filter. The control bags remained unfiltered. Each whole blood bag was then split into three smaller bags for further storage at 2-6°C, 20-24°C, or 33-37°C. Bacterial growth was quantified immediately, 2 and 3 h after inoculation, on days 1, 3, 7, and 14 for all storage temperatures, and on days 21 and 35 for storage at 2-6°C. Whole blood was inoculated with a median of 19.5 (range 12.0-32.0) colony-forming units per ml (CFU/ml) E. coli. After leukoreduction, a median of 3.3 CFU/ml (range 0.0-33.3) E. coli remained. In the control arm, the WBCs phagocytized E. coli within 24 h at 20-24°C and 33-37°C in 9 of 10 bags. During storage at 2-6°C, a slow self-sterilization occurred over time with and without leukoreduction. Storage at 20-24°C and 33-37°C for up to 24 h before leukoreduction reduces the risk of E. coli-contamination in CPDA-1 whole blood. Subsequent storage at 2-6°C will further reduce the growth of E. coli.
Sections du résumé
BACKGROUND
Collection of non-leukoreduced citrate-phosphate-dextrose-adenine (CPDA-1) whole blood is performed in walking blood banks. Blood collected under field conditions may have increased risk of bacterial contamination. This study was conducted to examine the effects of WBC reduction and storage temperature on growth of Escherichia coli (ATCC® 25922™) in CPDA-1 whole blood.
METHODS
CPDA-1 whole blood of 450 ml from 10 group O donors was inoculated with E. coli. Two hours after inoculation, the test bags were leukoreduced with a platelet-sparing filter. The control bags remained unfiltered. Each whole blood bag was then split into three smaller bags for further storage at 2-6°C, 20-24°C, or 33-37°C. Bacterial growth was quantified immediately, 2 and 3 h after inoculation, on days 1, 3, 7, and 14 for all storage temperatures, and on days 21 and 35 for storage at 2-6°C.
RESULTS
Whole blood was inoculated with a median of 19.5 (range 12.0-32.0) colony-forming units per ml (CFU/ml) E. coli. After leukoreduction, a median of 3.3 CFU/ml (range 0.0-33.3) E. coli remained. In the control arm, the WBCs phagocytized E. coli within 24 h at 20-24°C and 33-37°C in 9 of 10 bags. During storage at 2-6°C, a slow self-sterilization occurred over time with and without leukoreduction.
CONCLUSIONS
Storage at 20-24°C and 33-37°C for up to 24 h before leukoreduction reduces the risk of E. coli-contamination in CPDA-1 whole blood. Subsequent storage at 2-6°C will further reduce the growth of E. coli.
Substances chimiques
Citrates
0
citrate phosphate dextrose
51404-37-6
Glucose
IY9XDZ35W2
Adenine
JAC85A2161
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S80-S89Informations de copyright
© 2021 The Authors. Transfusion published by Wiley Periodicals LLC. on behalf of AABB.
Références
Sivertsen J, Braathen H, Lunde THF, Spinella PC, Dorlac W, Strandenes G, et al. Preparation of leukoreduced whole blood for transfusion in austere environments; effects of forced filtration, storage agitation, and high temperatures on hemostatic function. J Trauma Acute Care Surg. 2018;84:S93-S103.
Sivertsen J, Braathen H, Lunde THF, Kristoffersen EK, Hervig T, Strandenes G, et al. Cold-stored leukoreduced CPDA-1 whole blood: in vitro quality and hemostatic properties. Transfusion. 2020;60:1042-9.
Cap AP, Beckett A, Benov A, Borgman M, Chen J, Corley JB, et al. Whole blood transfusion. Mil Med. 2018;183:44-51.
Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, et al. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 2002;42:1356-64.
Bassuni WY, Blajchman MA, Al-Moshary MA. Why implement universal leukoreduction? Hematol Oncol Stem Cell Ther. 2008;1:106-23.
Fisher AD, Dunn J, Pickett JR, Garza J, Miles EA, Diep V, et al. Implementation of a low titer group O whole blood program for a law enforcement tactical team. Transfusion. 2020;60(Suppl 3):S36-44.
Widmer AF, Wiestner A, Frei R, Zimmerli W. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother. 1991;35:741-6.
Hakanen A, Huovinen P, Kotilainen P, Siitonen A, Jousimies-Somer H. Quality control strains used in susceptibility testing of campylobacter spp. J Clin Microbiol. 2002;40:2705-6.
Chen CL, Yu JC, Holme S, Jacobs MR, Yomtovian R, McDonald CP. Detection of bacteria in stored red cell products using a culture-based bacterial detection system. Transfusion. 2008;48:1550-7.
Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, et al. Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule. Vox Sang. 2013;105:100-7.
Ketter PM, Kamucheka R, Arulanandam B, Akers K, Cap AP. Platelet enhancement of bacterial growth during room temperature storage: mitigation through refrigeration. Transfusion. 2019;59:1479-89.
ATCC. Escherichia coli (ATCC 25922). In: Collection TATC ed. www.atcc.org; 2019.
Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493-9.
Perez P, Salmi LR, Folléa G, Schmit JL, de Barbeyrac B, Sudre P, et al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM case-control study. Transfusion. 2001;41:862-72.
Hamill TR, Hamill SG, Busch MP. Effects of room-temperature exposure on bacterial growth in stored red cells. Transfusion. 1990;30:302-6.
Hogman CF, Gong J, Eriksson L, Hambraeus A, Johansson CS. White cells protect donor blood against bacterial contamination. Transfusion. 1991;31:620-6.
Buchholz DH, AuBuchon JP, Snyder EL, Kandler R, Piscitelli V, Pickard C, et al. Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion. 1994;34:852-7.
Sanz C, Pereira A, Vila J, Faundez AI, Gomez J, Ordinas A. Growth of bacteria in platelet concentrates obtained from whole blood stored for 16 hours at 22 degrees C before component preparation. Transfusion. 1997;37:251-4.
Moroff G, AuBuchon JP, Pickard C, Whitley PH, Heaton WA, Holme S. Evaluation of the properties of components prepared and stored after holding of whole blood units for 8 and 24 hours at ambient temperature. Transfusion. 2011;51(Suppl 1):7s-14s.
Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, et al. Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth. Transfusion. 2013;53:851-9.
Kahn RA, Syring RL. The fate of bacteria introduced into whole blood from which platelet concentrates were prepared and stored at 22 or 4C. Transfusion. 1975;15:363-7.
Braude AI, Carey FJ, Siemienski J. Studies of bacterial transfusion reactions from refrigerated blood: the properties of cold-growing bacteria. J Clin Invest. 1955;34:311-25.
Huang L. Growth kinetics of Escherichia coli O157:H7 in mechanically-tenderized beef. Int J Food Microbiol. 2010;140:40-8.
Leijh PC, van den Barselaar MT, van Zwet TL, Dubbeldeman-Rempt I, van Furth R. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology. 1979;37:453-65.
Süss J, Bakács T, Balázs C. The phagocytosis capacity assay: a new radiometric phagocytosis test for clinical use. J Immunol Methods. 1982;53:69-75.
Walther-Wenke G. Incidence of bacterial transmission and transfusion reactions by blood components. Clin Chem Lab Med (CCLM). 2008;46:919.
Sowemimo-Coker SO. Red blood cell hemolysis during processing. Transfus Med Rev. 2002;16:46-60.
Kim DM, Brecher ME, Bland LA, Estes TJ, Carmen RA, Nelson EJ. Visual identification of bacterially contaminated red cells. Transfusion. 1992;32:221-5.
Netz UJ, Hirst L, Friebel M. Non-invasive detection of free hemoglobin in red blood cell concentrates for quality assurance. Photon Lasers Med. 2015;4:193-5.
Walther-Wenke G. Bacterial contamination of blood components-incidence and significance for homologous and autologous transfusion. J Lab Med. 2006;30:66-73.
Landsem A, Fure H, Christiansen D, Nielsen EW, Osterud B, Mollnes TE, et al. The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood. Clin Exp Immunol. 2015;182:81-9.
Lupu F, Keshari RS, Lambris JD, Coggeshall KM. Crosstalk between the coagulation and complement systems in sepsis. Thromb Res. 2014;133(Suppl 1):S28-31.
Matus V, Valenzuela JG, Hidalgo P, Pozo LM, Panes O, Wozniak A, et al. Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving toll like receptor 4. PLoS One. 2017;12:e0185431.
Seghatchian J. Bacterial contamination of blood components. Transfus Apher Sci. 2001;25:147-50.
Yomtovian R, Brecher ME. pH and glucose testing of single-donor apheresis platelets should be discontinued in favor of a more sensitive detection method. Transfusion. 2005;45:646-8.
Pidcoke HF, McFaul SJ, Ramasubramanian AK, Parida BK, Mora AG, Fedyk CG, et al. Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion. 2013;53(Suppl 1):137s-49s.
Meledeo MA, Peltier GC, McIntosh CS, Bynum JA, Cap AP. Optimizing whole blood storage: hemostatic function of 35-day stored product in CPD, CP2D, and CPDA-1 anticoagulants. Transfusion. 2019;59:1549-59.
Siblini L, Lafeuillade B, Ros A, Le Petit JC, Pozzetto B. Reduction of Yersinia enterocolitica load in deliberately inoculated blood: the effects of blood prestorage temperature and WBC filtration. Transfusion. 2002;42:422-7.
Kim DM, Brecher ME, Bland LA, Estes TJ, McAllister SK, Aguero SM, et al. Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters. Transfusion. 1992;32:658-62.